A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder
Clinical trial NCT00635076 · TERMINATED
Trial details
- NCT number
- NCT00635076
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.